Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.
Expert Committees
Advisory groups
Publications
All →
28 August 2025
Good practices for blood establishments
Blood transfusion is a vital component of modern health care and can be life-saving in many clinical situations. However, it is not without risks, including...
14 May 2025
WHO guideline on balanced national controlled medicines policies to ensure medical access and safety:...
WHO recommends that essential medicines, including those that are controlled, be available to all patients at all times at a price that the individual...
23 April 2025
Guidance on implementing patient blood management to improve global blood health status
Incorporating expertise from peers working in countries where health care faces extreme resource constraints, attention is paid to how PBM processes...
16 April 2025
WHO Drug Information - Volume 39, No. 1
The first issue of volume 39 for 2025 includes:Consultation Documents: - "Aminosalicylate sodium dihydrate (aminosalicylatum natricum dihydricus)"- "Aminosalicylate...
Journal articles
WHO informal consultation on the guidelines for evaluation of the quality, safety, and efficacy of DNA vaccines: Geneva, Switzerland, December 2019
npj Vaccines 5, 52 (2020)
WHO working group meeting to develop WHO Recommendations to assure the quality, safety and efficacy of enterovirus 71
Vaccine, Volume 38, Issue 32, 6 July 2020, Pages 4917-4923
Best Practices in Dengue Surveillance: A Report from the Asia-Pacific and Americas Dengue Prevention Boards
PLoS neglected tropical diseases vol. 4,11 e890. 16 Nov. 2010
